Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Beach

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Diagnostic Microbiology and Infectious Disease|May 26, 1999
Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America)G V Doern, R N Jones, M A Pfaller, et al.
Journal of Clinical Microbiology|May 15, 1999
Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzaeR N Jones, D J Biedenbach, M E Erwin, et al.
International Journal of Antimicrobial Agents|August 23, 2001
Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and developmentA M Fix, M A Pfaller, D J Biedenbach, et al.
Tobacco Control|February 28, 2001
Favourite movie stars, their tobacco use in contemporary movies, and its association with adolescent smokingJ J Tickle, J D Sargent, M A Dalton, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2000
Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methodsR N Jones, L M Deshpande, M E Erwin, et al.
American Journal of Perinatology|October 6, 1997
A comparison of neonatal outcomes of age-matched, growth-restricted twins and growth-restricted singletonsE R Baker, M L Beach, S D Craigo, et al.
American Journal of Epidemiology|April 1, 1996
Heterogeneity of hip fracture: age, race, sex, and geographic patterns of femoral neck and trochanteric fractures among the US elderlyM R Karagas, G L Lu-Yao, J A Barrett, et al.
Antimicrobial Agents and Chemotherapy|April 2, 1999
Comparison of activities of broad-spectrum beta-lactam compounds against 1,128 gram-positive cocci recently isolated in cancer treatment centersD J Diekema, S L Coffman, S A Marshall, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study GroupR N Jones, K C Kugler, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|June 4, 1999
Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study GroupR N Jones, D M Johnson, M E Erwin, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Diagnostic Microbiology and Infectious Disease|May 26, 1999
Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America)G V Doern, R N Jones, M A Pfaller, et al.
Journal of Clinical Microbiology|May 15, 1999
Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzaeR N Jones, D J Biedenbach, M E Erwin, et al.
International Journal of Antimicrobial Agents|August 23, 2001
Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and developmentA M Fix, M A Pfaller, D J Biedenbach, et al.
Tobacco Control|February 28, 2001
Favourite movie stars, their tobacco use in contemporary movies, and its association with adolescent smokingJ J Tickle, J D Sargent, M A Dalton, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2000
Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methodsR N Jones, L M Deshpande, M E Erwin, et al.
American Journal of Perinatology|October 6, 1997
A comparison of neonatal outcomes of age-matched, growth-restricted twins and growth-restricted singletonsE R Baker, M L Beach, S D Craigo, et al.
American Journal of Epidemiology|April 1, 1996
Heterogeneity of hip fracture: age, race, sex, and geographic patterns of femoral neck and trochanteric fractures among the US elderlyM R Karagas, G L Lu-Yao, J A Barrett, et al.
Antimicrobial Agents and Chemotherapy|April 2, 1999
Comparison of activities of broad-spectrum beta-lactam compounds against 1,128 gram-positive cocci recently isolated in cancer treatment centersD J Diekema, S L Coffman, S A Marshall, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study GroupR N Jones, K C Kugler, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|June 4, 1999
Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study GroupR N Jones, D M Johnson, M E Erwin, et al.
Pageof 4